2.The Effectiveness of Shakuyaku-kanzo-to on Myotonia in a Case of Myotonic Dystrophy.
Yoshikazu MASUI ; Nakaaki OHSAWA ; Hideto NAKAJIMA ; Mami YOSHIDA ; Tomonori SHIBUYA
Kampo Medicine 1996;46(5):773-778
The effectiveness of Shakuyaku-kanzo-to on myotonia in a 50-year-old female with myotonic dystrophy is reported. Neurological examination showed myogenic distal dominant muscle weakness and myotonia. Treatment with Shakuyaku-kanzo-to improved myotonic time from 12.8 to 6.8 seconds. This effect was equal to phenytoin and mexiletine. The results indicated that Shakuyaku-kanzo-to affected the ion channels of the skeletal muscle membrane. The apaminsensitive K channel was speculated to be the affected site of the ion channel. Glycyrrhizin might play an important role in this mechanism.
Five week treatment with Shakuyaku-kanzo-to showed no adverse effects on the myopathy.
3.Emaciated Patient with Slowly Progressed Type 1 Diabetes Mellitus who had hypoglycemia Despite Impaired Insulin Secretion
Takeshi Ito ; Nobuya Fujita ; Naoki Maeda ; Masayoshi Komura ; Hideto Tomioka ; Nobuki Ohnishi ; Kunihiko Arai ; Mizue Yokoyama ; Ryoji Yoshida
General Medicine 2009;10(1):23-27
We describe a 38-year-old, severely emaciated female with slowly progressive type 1 diabetes mellitus (SPIDDM), who had hypoglycemia due to fasting and an extremely low energy intake. After being diagnosed with diabetes mellitus (DM), she took in only 300-500 kcal per day and her weight had decreased to 30 kg, with a body mass index (BMI) of 11.4 kg/m2. She was admitted with hypoglycemia, and SPIDDM was confirmed by nearly-completely ceased insulin secretion and seropositivity towards anti-GAD antibody. After appropriate dietary therapy and insulin administration, she recovered from a state of emaciation and her glucose metabolism was restored. With this patient it proved very effective for the general physician to coordinate treatment for both diabetes and an eating disorder.
4.Validation of the Japanese Version of the STOP-Bang Test for the Risk Assessment of Obstructive Sleep Apnea Syndrome
Hideto OSHITA ; Hiroshi FUCHITA ; Noriaki ITO ; Misato SENOO ; Shoko ISOYAMA ; Yutaro YAMAMOTO ; Ayaka YOSHIDA ; Keiko OSAKI ; Kohei KAWASAKI ; Ken OKUSAKI
An Official Journal of the Japan Primary Care Association 2019;42(1):26-31
Objective: The objective of this study was to validate the Japanese version of the STOP-Bang test for risk assessment of obstructive sleep apnea syndrome (OSAS).Methods: We retrospectively evaluated inpatients who underwent nocturnal pulse oximetry for OSAS screening at the internal medical wards.Results: One hundred and forty-four subjects were included the study, and 57 subjects who had a 3% oxygen desaturation index ≥10/hr underwent polysomnography. Seventeen and 29 subjects were diagnosed with moderate and severe OSAS, respectively. According to the receiver operating characteristic (ROC) curve analysis, the STOP-Bang test had a higher diagnostic value using a cutoff of 30 kg/m2 for BMI than using a cutoff of 35 kg/m2. A STOP-Bang score of 3 or greater had a sensitivity of 95.7% and specificity of 42.9% for detecting moderate-to-severe OSAS.Conclusion: The STOP-Bang test is a simple and useful tool for the risk assessment of OSAS.